For the year ending 2025-12-31, EKSO has $20,111K in assets. $11,084K in debts. $1,169K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash | 1,169 | |||
| Restricted cash | 0 | |||
| Accounts receivable, net of allowances of 27 and 33, respectively | 7,308 | |||
| Inventories | 4,822 | |||
| Prepaid expenses and other current assets | 750 | |||
| Total current assets | 14,049 | |||
| Property and equipment, net | 1,288 | |||
| Right-of-use assets | 532 | |||
| Intangible assets, net | 3,500 | |||
| Goodwill | 431 | |||
| Other assets | 311 | |||
| Total assets | 20,111 | |||
| Accounts payable | 1,431 | |||
| Accrued liabilities | 1,779 | |||
| Deferred revenues, current | 1,727 | |||
| Convertible promissory note, net | 2,008 | |||
| Notes payable, current | 1,250 | |||
| Lease liabilities, current | 441 | |||
| Total current liabilities | 8,636 | |||
| Deferred revenues | 1,414 | |||
| Notes payable, net | 798 | |||
| Lease liabilities | 147 | |||
| Warrant liabilities | 0 | |||
| Other non-current liabilities | 89 | |||
| Total liabilities | 11,084 | |||
| Common stock, 0.001 par value 141,429 shares authorized 3,559 and 1,480 shares issued and outstanding as of december 31, 2025 and 2024, respectively | 37 | |||
| Additional paid-in capital | 272,078 | |||
| Accumulated other comprehensive (loss) income | -692 | |||
| Accumulated deficit | -262,396 | |||
| Total stockholders' equity | 9,027 | |||
| Total liabilities and stockholders' equity | 20,111 | |||
EKSO BIONICS HOLDINGS, INC. (EKSO)
EKSO BIONICS HOLDINGS, INC. (EKSO)